{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:17:27Z","timestamp":1792052247357,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00296-021-04855-x","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T05:02:40Z","timestamp":1618203760000},"page":"1203-1208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9857-0842","authenticated-orcid":false,"given":"George","family":"Iliopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8027-3655","authenticated-orcid":false,"given":"Dimitrios","family":"Daoussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"4855_CR1","first-page":"753","volume-title":"Expert review of clinical immunology","author":"M Cutolo","year":"2019","unstructured":"Cutolo M, Soldano S, Smith V (2019) Pathophysiology of systemic sclerosis: current understanding and new insights. Expert review of clinical immunology, vol 15. Taylor and Francis Ltd, Milton Park, pp 753\u2013764"},{"key":"4855_CR2","first-page":"20","volume-title":"RMD Open","author":"V Smith","year":"2018","unstructured":"Smith V, Scir\u00e8 CA, Talarico R, Airo P, Alexander T, Allanore Y et al (2018) Systemic sclerosis: State of the art on clinical practice guidelines. RMD Open, vol 4. BMJ Publishing Group, London, p 20"},{"issue":"9","key":"4855_CR3","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/jcm9092687","volume":"9","author":"Y Asano","year":"2020","unstructured":"Asano Y (2020) The pathogenesis of systemic sclerosis: an understanding based on a common pathologic cascade across multiple organs and additional organ-specific pathologies. J Clin Med 9(9):2687","journal-title":"J Clin Med"},{"key":"4855_CR4","first-page":"S3","volume":"119","author":"S Barsotti","year":"2019","unstructured":"Barsotti S, Orlandi M, Codullo V, Di Battista M, Lepri G, Della RA et al (2019) One year in review 2019: systemic sclerosis. Clin Exp Rheumatol 119:S3-14","journal-title":"Clin Exp Rheumatol"},{"key":"4855_CR5","first-page":"1685","volume-title":"Systemic sclerosis","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis, vol 390. Lancet Publishing Group, London, pp 1685\u20131699"},{"issue":"7","key":"4855_CR6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis 66(7):940\u2013944","journal-title":"Ann Rheum Dis"},{"key":"4855_CR7","first-page":"687","volume-title":"Seminars in arthritis and rheumatism","author":"N Bose","year":"2015","unstructured":"Bose N, Chiesa-Vottero A, Chatterjee S (2015) Scleroderma renal crisis. Seminars in arthritis and rheumatism, vol 44. W.B. Saunders, Philadelphia, pp 687\u2013694"},{"key":"4855_CR8","first-page":"304","volume-title":"The Lancet respiratory medicine","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi AV, Highland KB (2020) Systemic sclerosis-associated interstitial lung disease. The Lancet respiratory medicine, vol 8. Lancet Publishing Group, London, pp 304\u2013320"},{"key":"4855_CR9","doi-asserted-by":"crossref","unstructured":"Anders HJ, Saxena R, Zhao-hui M, Parodis I, Salmon JE, Mohan C (2020) Lupus nephritis. Vol. 6. Nature Reviews Disease Primers. Nature Research","DOI":"10.1038\/s41572-019-0141-9"},{"key":"4855_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40620-017-0412-z","volume":"31","author":"V Binda","year":"2018","unstructured":"Binda V, Moroni G, Messa P (2018) ANCA-associated vasculitis with renal involvement. J Nephrol (Springer) 31:197\u2013208","journal-title":"J Nephrol (Springer)"},{"issue":"3","key":"4855_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/ard.2008.105049","volume":"69","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Panoulas VF, Antonopoulos I, John H, Toms TE, Wong P et al (2010) Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 69(3):517","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4855_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/acr.22713","volume":"68","author":"M Couderc","year":"2016","unstructured":"Couderc M, Tatar Z, Pereira B, Tiple A, Gilson M, Fautrel B et al (2016) Prevalence of renal impairment in patients with rheumatoid arthritis: results from a cross-sectional multicenter study. Arthritis Care Res (Hoboken) 68(5):638\u2013644","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"4855_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1573403X14666180711124825","volume":"15","author":"NG Vallianou","year":"2018","unstructured":"Vallianou NG, Mitesh S, Gkogkou A, Geladari E (2018) Chronic kidney disease and cardiovascular disease: is there any relationship? Curr Cardiol Rev 15(1):55\u201363","journal-title":"Curr Cardiol Rev"},{"issue":"8","key":"4855_CR14","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1681\/ASN.2006030204","volume":"17","author":"K Amann","year":"2006","unstructured":"Amann K, Wanner C, Ritz E (2006) Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol 17(8):2112\u20132119","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"4855_CR15","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00296-019-04371-z","volume":"39","author":"E Pagkopoulou","year":"2019","unstructured":"Pagkopoulou E, Arvanitaki A, Daoussis D, Garyfallos A, Kitas G, Dimitroulas T (2019) Comorbidity burden in systemic sclerosis: beyond disease-specific complications. Rheumatol Int 39(9):1507\u20131517","journal-title":"Rheumatol Int"},{"key":"4855_CR16","doi-asserted-by":"crossref","unstructured":"Vart P, Grams ME (2016) Measuring and assessing kidney function. Seminars in nephrology (W.B. Saunders) 36: 262\u201372.","DOI":"10.1016\/j.semnephrol.2016.05.003"},{"issue":"9","key":"4855_CR17","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3899\/jrheum.111417","volume":"39","author":"M Caron","year":"2012","unstructured":"Caron M, Hudson M, Baron M, Nessim S, Steele R, Pope J et al (2012) Longitudinal study of renal function in systemic. J Rheumatol 39(9):1829\u20131834","journal-title":"J Rheumatol"},{"issue":"4","key":"4855_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/03009740802629424","volume":"38","author":"A Scheja","year":"2009","unstructured":"Scheja A, Bartosik I, Wuttge DM, Hesselstrand R (2009) Renal function is mostly preserved in patients with systemic sclerosis. Scand J Rheumatol 38(4):295\u2013298","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"4855_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/0019-5359.30349","volume":"61","author":"R Gupta","year":"2007","unstructured":"Gupta R, Bammigatti C, Dinda AK, Marwaha V, Gupta S (2007) Prevalence of renal involvement in Indian patients with systemic sclerosis. Indian J Med Sci 61(2):91\u201396","journal-title":"Indian J Med Sci"},{"issue":"3","key":"4855_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1159\/000489740","volume":"43","author":"E Rosato","year":"2018","unstructured":"Rosato E, Gigante A, Barbano B, Gasperini ML, Cianci R, Muscaritoli M (2018) Prognostic factors of renal involvement in systemic sclerosis. Kidney Blood Press Res 43(3):682\u2013689","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"4855_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.amjms.2016.04.017","volume":"352","author":"P Suebmee","year":"2016","unstructured":"Suebmee P, Foocharoen C, Mahakkanukrauh A, Suwannaroj S, Theerakulpisut D, Nanagara R (2016) Correlation of glomerular filtration rate between renal scan and estimation equation for patients with scleroderma. Am J Med Sci 352(2):166\u2013171","journal-title":"Am J Med Sci"},{"issue":"8","key":"4855_CR22","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1093\/rheumatology\/kes049","volume":"51","author":"A Gigante","year":"2012","unstructured":"Gigante A, Rosato E, Massa R, Rossi C, Barbano B, Cianci R et al (2012) Evaluation of chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in scleroderma patients. Rheumatology 51(8):1426\u20131431","journal-title":"Rheumatology"},{"issue":"7","key":"4855_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10067-010-1389-3","volume":"29","author":"RHA Mohamed","year":"2010","unstructured":"Mohamed RHA, Zayed HS, Amin A (2010) Renal disease in systemic sclerosis with normal serum creatinine. Clin Rheumatol 29(7):729\u2013737","journal-title":"Clin Rheumatol"},{"key":"4855_CR24","doi-asserted-by":"publisher","first-page":"R690","DOI":"10.1152\/ajpregu.00237.2020","volume":"319","author":"AH Jufar","year":"2020","unstructured":"Jufar AH, Lankadeva YR, May CN, Cochrane AD, Bellomo R, Evans RG (2020) Renal functional reserve: From physiological phenomenon to clinical biomarker and beyond. Am J Physiol Regul Integr Comp Physiol 319:R690-702","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"4855_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10067-012-1963-y","volume":"31","author":"A Amin","year":"2012","unstructured":"Amin A, El-Sayed S, Taher N, Sedki M, Nasr H (2012) Tc-99m diethylenetriamine pentaacetic acid (DTPA) renal function reserve estimation: is it a reliable predictive tool for assessment of preclinical renal involvement in scleroderma patients. Clin Rheumatol 31(6):961\u2013966","journal-title":"Clin Rheumatol"},{"issue":"11","key":"4855_CR26","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1136\/ard.2011.152892","volume":"70","author":"R Livi","year":"2011","unstructured":"Livi R, Guiducci S, Perfetto F, Ciuti G, Grifoni E, Conforti L et al (2011) Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. Ann Rheum Dis 70(11):1963\u20131967","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"4855_CR27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/ard.61.8.682","volume":"61","author":"R Livi","year":"2002","unstructured":"Livi R, Teghini L, Pignone A, Generini S, Matucci-Cerinic M, Cagnoni M (2002) Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement. Ann Rheum Dis 61(8):682\u2013686","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4855_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5414\/CNP70110","volume":"70","author":"B Seiberlich","year":"2008","unstructured":"Seiberlich B, Hunzelmann N, Krieg T, Weber M, Schulze-Lohoff E (2008) Intermediate molecular weight proteinuria and albuminuria identify scleroderma patients with increased morbidity. Clin Nephrol 70(2):110\u2013117","journal-title":"Clin Nephrol"},{"issue":"9","key":"4855_CR29","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s00296-013-2691-6","volume":"33","author":"J Schuster","year":"2013","unstructured":"Schuster J, Moinzadeh P, Kurschat C, Benzing T, Krieg T, Weber M et al (2013) Proteinuria in systemic sclerosis: reversal by ACE inhibition. Rheumatol Int 33(9):2225\u20132230","journal-title":"Rheumatol Int"},{"issue":"1","key":"4855_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.31138\/mjr.30.1.33","volume":"30","author":"D Daoussis","year":"2019","unstructured":"Daoussis D, Liossis S-N (2019) Treatment of systemic sclerosis associated fibrotic manifestations: current options and future directions. Mediterr J Rheumatol 30(1):33\u201337","journal-title":"Mediterr J Rheumatol"},{"key":"4855_CR31","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00296-019-04357-x","volume":"39","author":"K Melissaropoulos","year":"2019","unstructured":"Melissaropoulos K, Kraniotis P, Bogdanos D, Dimitroulas T, Sakkas L, Daoussis D (2019) Targeting very early systemic sclerosis: a case-based review. Rheumatol Int (Springer) 39:1961\u20131970","journal-title":"Rheumatol Int (Springer)"},{"issue":"1","key":"4855_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12882-017-0749-5","volume":"18","author":"P Trocchi","year":"2017","unstructured":"Trocchi P, Girndt M, Scheidt-Nave C, Markau S, Stang A (2017) Impact of the estimation equation for GFR on population-based prevalence estimates of kidney dysfunction. BMC Nephrol 18(1):341","journal-title":"BMC Nephrol"},{"issue":"2","key":"4855_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.ajkd.2013.08.010","volume":"63","author":"LJ Hickson","year":"2014","unstructured":"Hickson LJ, Crowson CS, Gabriel SE, McCarthy JT, Matteson EL (2014) Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis 63(2):206\u2013213","journal-title":"Am J Kidney Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04855-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04855-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04855-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T13:05:23Z","timestamp":1622293523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04855-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4855"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04855-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}